Author： Bushnell Cheryl
Publisher： Informa Healthcare
ISSN： 1474-0338
Source： Expert Opinion on Drug Safety, Vol.4, Iss.3, 2005-05, pp. : 501-507
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Tamoxifen use associated with reduction in breast density
Inpharma, Vol. 1, Iss. 1436, 2004-01 ,pp. :
Access to resources
Recommend
Risks associated with the therapeutic use of fluoroquinolones
By Stahlmann Ralf Lode Hartmut M
Expert Opinion on Drug Safety, Vol. 12, Iss. 4, 2013-07 ,pp. :
Tamoxifen associated with uterine sarcoma
Inpharma, Vol. 1, Iss. 1342, 2002-01 ,pp. :
Potential Risks Associated with the Use of Herbal Anti-Obesity Products
Drug Safety, Vol. 32, Iss. 6, 2009-05 ,pp. :